123 related articles for article (PubMed ID: 38575828)
1. Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system?
Chu QD; Li T; Hsieh MC; Yi Y; Gibbs JF; Sahawneh J; Sang W; Gallagher J; Wu XC
Surg Endosc; 2024 May; 38(5):2857-2870. PubMed ID: 38575828
[TBL] [Abstract][Full Text] [Related]
2. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy.
Chu QD; Zhou M; Medeiros KL; Peddi P; Kavanaugh M; Wu XC
BMC Cancer; 2016 Jul; 16():460. PubMed ID: 27412163
[TBL] [Abstract][Full Text] [Related]
3. Positive surgical margins contribute to the survival paradox between patients with stage IIB/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer.
Chu QD; Zhou M; Medeiros K; Peddi P
Surgery; 2016 Nov; 160(5):1333-1343. PubMed ID: 27425043
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox.
Kim HS; Kim KM; Lee SB; Kim GR; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
J Surg Oncol; 2019 Sep; 120(3):423-430. PubMed ID: 31134644
[TBL] [Abstract][Full Text] [Related]
5. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer.
Kim MJ; Jeong SY; Choi SJ; Ryoo SB; Park JW; Park KJ; Oh JH; Kang SB; Park HC; Heo SC; Park JG
Ann Surg Oncol; 2015 Feb; 22(2):505-12. PubMed ID: 25145501
[TBL] [Abstract][Full Text] [Related]
6. Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer.
Li H; Fu G; Wei W; Huang Y; Wang Z; Liang T; Tian S; Chen H; Zhang W
Front Oncol; 2020; 10():595107. PubMed ID: 33312954
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy exacerbates the survival paradox of colon cancer: a propensity score matching analysis.
Tian M; Zhou Z
Transl Cancer Res; 2022 Dec; 11(12):4241-4253. PubMed ID: 36644182
[TBL] [Abstract][Full Text] [Related]
8. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous survival between stage IIA and stage IIIA colon cancer when different numbers of lymph nodes are harvested.
Huang B; Feng Y; Ni M; Chen C; Cai G
ANZ J Surg; 2018 Apr; 88(4):316-321. PubMed ID: 27580642
[TBL] [Abstract][Full Text] [Related]
10. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
11. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
[TBL] [Abstract][Full Text] [Related]
12. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.
O'Connell JB; Maggard MA; Ko CY
J Natl Cancer Inst; 2004 Oct; 96(19):1420-5. PubMed ID: 15467030
[TBL] [Abstract][Full Text] [Related]
13. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
[TBL] [Abstract][Full Text] [Related]
14. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
15. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
16. How does lymph node yield affect survival outcomes of stage I and II colon cancer?
Foo CC; Ku C; Wei R; Yip J; Tsang J; Chan TY; Lo O; Law WL
World J Surg Oncol; 2020 Jan; 18(1):22. PubMed ID: 31996214
[TBL] [Abstract][Full Text] [Related]
17. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
18. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.
Abdel-Rahman O
Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248
[TBL] [Abstract][Full Text] [Related]
19. Hospital lymph node examination rates and survival after resection for colon cancer.
Wong SL; Ji H; Hollenbeck BK; Morris AM; Baser O; Birkmeyer JD
JAMA; 2007 Nov; 298(18):2149-54. PubMed ID: 18000198
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
